@FierceMedDev: 'Awake Imaging' boosts Dx prospects for fidgety patients. Article | Follow @FierceMedDev
@MarkHFierce: BSD will use Japan's Terumo to reach global markets with its cancer ablation device. More | Follow @MarkHFierce
@DamianFierce: Quintiles' founder and early investors will make off with $25M once the CRO goes public. Story | Follow @DamianFierce
> Boston Scientific ($BSX) has sold its old Natick, MA, headquarters to software company Math Works for $55 million. The devicemaker is in the process of relocating to nearby Marlborough. Article
> Stryker ($SYK) has appointed a new CFO, recruiting former Dentsply International vice president William Jellison. More
> Medimetrics has joined the Netherlands' Nizo Food Research to use its IntelliCap device to conduct in vivo tests of gastric responses to foods. Article
> About 30% of medical device startups plan to pass along most or all of the device tax's increase costs, according to the Startup Outlook 2013 survey; while 77% of those surveyed say they plan to hire this year. Story
> Monteris Medical gained a second FDA 510(k) clearance for its second-generation NeuroBlate MRI-guided ablation device to treat brain tumors and other lesions. Item
> Amarantus Bioscience plans to begin a small clinical performance study using its LymPro blood test to diagnose Alzheimer's disease in the fiscal 2013 second quarter, with a pivotal study likely later in the year. Release
> Medical device approvals climbed 7% from 2011 to 2012, due to increased demand from an aging population. Story
Biotech News
@FierceBiotech: Pharmacyclics bounces higher as J&J wins third 'breakthrough' cancer drug coup. More | Follow @FierceBiotech
@JohnCFierce: Roche rolls out $392M Isis pact in two-prong attack on Huntington's. Story | Follow @JohnCFierce.
@RyanMFierce: Uh oh. biotech outfit Unigene is slashing ~40% of workers to extend cash runway. Release | Follow @RyanMFierce
> Investigator says 'insane' rules are blocking his study on magic mushrooms. More
> Blue chip venture groups arm gene therapy upstart with $41M launch round. News
> In Sunday surprise, Bristol-Myers' R&D chief replaced by lieutenant. Report
Pharma News
@FiercePharma: Merck's new Fosamax trial starts today. Was woman's atypical femur fracture caused by drug, or disease? More | Follow @FiercePharma
@EricPFierce: India delays to 2014 its deadline for drugmakers to put bar codes on primary packaging to fight fakes. More | Follow @EricPFierce
> Merz drops out of Obagi bidding, handing $417M deal to Valeant. News
> U.S. drugmakers Pfizer, J&J top reputation ranks in Germany, Italy. Story
> Orphan drugs join the price-squeeze club in Europe. Report
CRO News
> InVentiv sells sample management biz to Knipper. More
> Indian trial reform on the way, but does it make sense? Article
> EU CRO TranScrip launches U.S. operation. Item
> AmerisourceBergen sells contract packaging biz for $308M. More
> Bristol-Myers picks LabCorp for CRO work. Story
Biotech IT News
> Survey: Cloud computing tops pharma's IT plans. More
> Life Tech genome software aids cancer-drug hunters in pharma. Report
> New trial search engine steps into congested market. Story
> Big Data hits Eastern Europe as IBM fires up supercomputer. Item
> Computational scientists clear path to potential Parkinson's drugs. Article